Latest Breaking News On - Grifols group - Page 2 : comparemela.com

Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate

EQS-News: Biotest AG / Key word: Study results Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate 14.02.2024 / 08:30.

Comunidad autonoma de catalunaUnited statesSilke aignerMonika baumann buttkereitDirk neumGrifols groupDevelopment at biotestPrime standardMonika baumann

Biotest increases EBIT to Euro 125 4 million in the first nine months of 2023

EQS-News: Biotest AG / Key word: 9 Month figures Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023 02.11.2023 / 08:00 CET/CEST The issuer.

United kingdomComunidad autonoma de catalunaUnited statesDirk neumMonika baumann buttkereitBiotest groupGrifols groupStandard of the german stock exchangeDrug administrationBiotest next levelBiotest nextBiologics license applicationIgg next generationQuarterly reportsPrime standardGerman stock

Araclon Biotech Presents Positive Final Results from Phase 2 Clinical Study of ABvac40 Alzheimer s Vaccine at CTAD

Araclon Biotech Presents Positive Final Results from Phase 2 Clinical Study of ABvac40 Alzheimer s Vaccine at CTAD
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesBaja californiaComunidad autonoma de catalunaBoada roviraJose terencioTeaes tesaesAlzheimer associationSpanish stock exchangeMedia press officeInvestors relations department sustainabilityAce alzheimer centerGrifols groupBiotech presents positive final resultsMini mental state examinationDisease factsRepeatable battery

Araclon s Alzheimer s Vaccine Shows Clean Safety Profile in Phase II Analysis

While the trial was designed to test safety and not efficacy, patients treated with Araclon Biotech’s experimental ABvac40 vaccine saw a 38% drop in disease progression compared to placebo.

Jose terencioBoada roviraArtur plawgoGrifols groupElan pharmaceuticalsMini mental state examinationRepeatable batteryNeuropsychological statusTrial making testFast track designationRaclons alzheimers vaccine shows clean safety profile in phase ii analysis

Araclon Biotech Presents Positive Final Results from Phase 2 Clinical Study of ABvac40 Alzheimer s Vaccine at CTAD

Araclon Biotech Presents Positive Final Results from Phase 2 Clinical Study of ABvac40 Alzheimer s Vaccine at CTAD
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBaja californiaComunidad autonoma de catalunaTeaes tesaesBoada roviraJose terencioGrifols groupInvestors relations department sustainabilityAlzheimer associationMedia press office telSpanish stock exchangeAce alzheimer centerMini mental state examinationDisease factsRepeatable batteryNeuropsychological status